Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYCRISPR Therapeutics and Vertex Pharmaceuticals Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to CTX001™ for the Treatment of Sickle Cell DiseasePREV STORYIn vitro Diagnostics Market is Forecast to Rise at 4.5% CAGR and Reach USD 87.11 Billion by 2026; Launch of Altostar Molecular Diagnostics Workflow by Altona Diagnostics Gmbh Will Support Growth, says Fortune Business Insights